Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's…
NCT00055783 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00055783 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma |
| Official title | A Phase II Study of Hu1D10 in Recurrent Hodgkin's Disease |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological |
| Interventions | apolizumab |
| Start date | Jul 1, 2002 |
| Completion | Apr 1, 2003 |
| First posted | Mar 7, 2003 |
| Last update posted | May 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: